scispace - formally typeset
Journal ArticleDOI

Association of Baseline Diuretic Use With Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction: A Secondary Analysis From TOPCAT.

Sadiya S. Khan, +7 more
- 24 Feb 2021 - 
- Vol. 27, Iss: 7, pp 816-818
Reads0
Chats0
About: 
This article is published in Journal of Cardiac Failure.The article was published on 2021-02-24. It has received 1 citations till now. The article focuses on the topics: Heart failure with preserved ejection fraction.

read more

Citations
More filters
Journal ArticleDOI

Efficacy and safety of diuretics in heart failure with preserved ejection fraction: a scoping review.

Arushi Singh, +6 more
- 02 Aug 2021 - 
TL;DR: In this article, the authors conducted a scoping review to map trial data of diuretic efficacy and safety in patients with heart failure with preserved ejection fraction (HFpEF).
References
More filters
Journal ArticleDOI

Spironolactone for Heart Failure with Preserved Ejection Fraction

Bertram Pitt, +22 more
- 09 Apr 2014 - 
TL;DR: In patients with heart failure and a preserved ejection fraction, treatment with spironolactone did not significantly reduce the incidence of the primary composite outcome of death from cardiovascular causes, aborted cardiac arrest, or hospitalization for the management of heart failure.
Journal ArticleDOI

Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial

Marc A. Pfeffer, +20 more
- 06 Jan 2015 - 
TL;DR: This post hoc analysis demonstrated greater potassium and creatinine changes and possible clinical benefits with spironolactone in patients with heart failure and preserved ejection fraction from the Americas.
Journal ArticleDOI

Empagliflozin in Heart Failure: Diuretic and Cardiorenal Effects

Matthew D. Griffin, +19 more
- 15 Sep 2020 - 
TL;DR: Empagliflozin causes significant natriuresis, particularly when combined with loop diuretics, resulting in an improvement in blood volume, and may represent a mechanism contributing to the superior long-term heart failure outcomes observed with these agents.
Journal ArticleDOI

Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial

Zachary L. Cox, +3 more
- 01 Mar 2020 - 
TL;DR: In this moderately sized DR trial, weight loss was excellent with the addition of metolazone, IV chlorothiazide, or tolvaptan to loop diuretics, without a detectable between-group difference.
Journal ArticleDOI

Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.

Ambarish Pandey, +9 more
- 01 Feb 2017 - 
TL;DR: Troponin elevation among patients with acutely decompensated HFpEF is associated with worse in-hospital and postdischarge outcomes, independent of other predictive variables.
Related Papers (5)

Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone

Amil M. Shah, +9 more
- 16 Oct 2015 - 

Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension

Tetsuro Tsujimoto, +1 more
- 01 Dec 2020 - 

Cardiac Structure and Function and Prognosis in Heart Failure With Preserved Ejection Fraction

Amil M. Shah, +19 more
- 01 Sep 2014 - 

What Have We Learned About Patients With Heart Failure and Preserved Ejection Fraction From DIG-PEF, CHARM-Preserved, and I-PRESERVE?

Ross T. Campbell, +5 more
- 11 Dec 2012 - 

The treatment of heart failure with preserved ejection fraction ("diastolic heart failure").

Karen Hogg, +1 more
- 01 Jun 2006 -